Raphaël de Coninck will be speaking at a seminar on recent antitrust developments in the pharmaceutical sector. Details are available here.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...